You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00904-7440


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00904-7440

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00904-7440 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00904-7440

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a drug identified by the NDC 00904-7440, it is crucial to understand what an NDC is. The National Drug Code (NDC) is a unique 10-digit, three-segment number assigned to medication in the United States. This code identifies the labeler, product, and trade package size of the drug[1][4].

Breakdown of the NDC 00904-7440

  • Labeler Code: The first segment (00904) identifies the company that manufactures or distributes the drug.
  • Product Code: The second segment (744) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (0) identifies the package size and type.

Market Trends in the Pharmaceutical Industry

Global Pricing Disparities

The pharmaceutical industry is marked by significant pricing disparities between the U.S. and other regions. In 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[3].

Sales Revenue Trends

U.S. sales revenues for pharmaceuticals have shown substantial growth, particularly in the non-retail market (hospitals and physician offices), with a 26% increase from 2017 to 2022. In contrast, retail market sales in other regions have declined[3].

Impact of Generic and Biosimilar Drugs

The life sciences industry is facing increased competition from generic drugs and biosimilars. This competition is expected to be a significant trend in 2025, with 37% of surveyed executives viewing it as a top concern. The patent cliff, with over $300 billion in sales at risk through 2030, is also driving interest in mergers and acquisitions[5].

Role of Digital Transformation and AI

Digital transformation and the integration of artificial intelligence (AI) are expected to play pivotal roles in the pharmaceutical industry in 2025. AI is predicted to enhance standard operations in clinical development, improve drug discovery and therapy development, and optimize clinical trials[2].

Pricing and Access

Pricing and access to drugs remain significant issues for the life sciences industry. Nearly half of surveyed executives expect these factors to significantly affect their strategies in 2025. Companies are exploring various initiatives to navigate these pressures, including advances in personalized medicine and the use of AI to improve operational efficiencies[5].

NDC Pricing and Billing

NDC codes are crucial for accurate billing and payment. The NDC/HCPCS crosswalk file helps in assigning NDC-identified drugs to Level II HCPCS billing codes, ensuring correct payment and control of drug costs[1].

Price Projections for NDC 00904-7440

Given the broader market trends:

  • Global Pricing: The drug's price in the U.S. is likely to remain higher compared to other regions due to the existing pricing disparities.
  • Competition: If the drug faces competition from generics or biosimilars, its price could be impacted, potentially leading to a decrease.
  • Digital Transformation: The use of AI and other digital technologies could lead to more efficient production and distribution, which might stabilize or reduce prices.

Example of Price Impact

For instance, if the drug is a small molecule drug, U.S. sales revenues for such drugs grew only 4% from 2017 to 2022, which is relatively slow compared to biologic products. This slow growth could indicate stable or slightly increasing prices for the drug in question[3].

Key Takeaways

  • NDC Importance: The NDC code is essential for identifying and billing drugs accurately.
  • Pricing Disparities: U.S. prices for drugs are significantly higher than in other regions.
  • Competition: Generic and biosimilar competition can impact drug prices.
  • Digital Transformation: AI and digital technologies are expected to enhance operational efficiencies and potentially stabilize prices.
  • Pricing and Access: These remain critical issues for the life sciences industry in 2025.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique 10-digit, three-segment number assigned to medication in the United States, identifying the labeler, product, and trade package size.
  2. Why are NDC codes important for coders and billers?

    • NDC codes help ensure correct payment and control of drug costs by accurately identifying the drugs administered and billed.
  3. How do global pricing disparities affect drug prices in the U.S.?

    • Drug prices in the U.S. are significantly higher than in other regions, with prices being 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world.
  4. What impact do generic and biosimilar drugs have on the pharmaceutical market?

    • Generic and biosimilar drugs increase competition, which can lead to lower prices for the original drugs and affect the market strategies of pharmaceutical companies.
  5. How is AI expected to influence the pharmaceutical industry in 2025?

    • AI is expected to enhance standard operations in clinical development, improve drug discovery and therapy development, and optimize clinical trials, among other applications.

Sources

  1. AAPC - NDC Code Lookup
  2. Intelligencia.ai - 2025 Pharma Predictions
  3. ASPE - International Market Size and Prices
  4. FDA - National Drug Code Database Background Information
  5. Deloitte Insights - 2025 Life Sciences Executive Outlook

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.